$ Value
$3K
Shares
119
Price
$27
Filed
Nov 5
Insider
Name
Palasis Maria
Title
—
CIK
0001810701
Roles
Transaction Details
Transaction Date
2025-10-31
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
9,841
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025. | The weighted average sale price for the transaction reported was $26.8588 and the range of prices were between $26.27 and $27.22. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | The weighted average sale price for the transaction reported was $27.4502 and the range of prices were between $27.32 and $27.57. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Filing Info
Palasis Maria's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | LYRA | D | $0 |
| 2026-01-13 | BBNX | A | $0 |
| 2026-01-06 | LYRA | ▼ | $6K |
| 2025-12-01 | BBNX | ▼ | $27K |
| 2025-12-01 | BBNX | ▼ | $15K |
| 2025-10-31 | BBNX | ▼ | $35K |
| 2025-10-31 | BBNX | ▼ | $3K |
| 2025-10-01 | LYRA | A | $0 |
| 2025-07-10 | LYRA | ▼ | $14K |
Other Insiders at BBNX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hopman Mark
Chief Commercial Officer
|
— | $103K | 2026-03-04 |
|
Mensinger Mike
Chief Product Officer
|
— | $13K | 2026-03-02 |
|
Feider Stephen
Chief Financial Officer
|
— | $18K | 2026-03-02 |
|
Saint Sean
President & CEO
|
— | $42K | 2026-03-02 |
|
Russell Steven Jon
Chief Medical Officer
|
— | $43K | 2026-03-02 |